JPRN-UMIN000046094
Recruiting
未知
Molecular imaging for pathophysiologic evaluation of dementia-related neurodegenerative diseases - Molecular imaging of dementia
niversity of Fukui0 sites150 target enrollmentNovember 17, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with dementia and healthy subjects of the same age group who meet all the criteria.
- Sponsor
- niversity of Fukui
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with complications of organic brain diseases other than the target disease 2\. Patients with complications from serious diseases 3\. Patients with claustrophobia 4\. Patients with pacemakers or internal metal (brain clips, bolts, etc.) 5\. Patients with tattoos (including artistic makeup) 6\. Patients who are pregnant, may become pregnant, or are breastfeeding 7\. Other patients who are judged by the principal investigator or sub\-investigator to be unsuitable as subjects.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Molecular imaging for the early diagnosis and monitoring of Alzheimer’s disease in old individuals with cognitive disturbancesMild Congitive Impairment (MCI)MedDRA version: 14.1Level: LLTClassification code 10050727Term: RI scanSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2011-004415-24-ITIRCCS CENTRO SAN GIOVANNI DI DIO
Completed
Not Applicable
ProMOTE EMI-137: Prostate Molecular Targeting to Enhance surgery using EMI-137ISRCTN97555789niversity of Oxford2
Completed
Not Applicable
ovel noninvasive molecular imaging modalities for ischemia in peripheral arterial diseaseexertional leg painperipheral arterial disease1002830210003216NL-OMON42178Academisch Medisch Centrum50
Suspended
Phase 1
Prostate MOlecular Targeting to Enhance surgery using IR800 IAB2MProstate CancerCancerISRCTN10046036niversity of Oxford23
Completed
Not Applicable
Various imaging and molecular biomarkers prognosticating diabetic macular edemaHealth Condition 1: H350- Background retinopathy and retinalvascular changesCTRI/2020/11/028787PGIMER Chandigarh18